Latest News & Features
Refine Search
Big Pharma
The Philippines Food and Drug Administration has issued a closure notice for a company allegedly responsible for producing counterfeit rabies vaccines. 4 February 2019
Americas
Generic-drug manufacturers Mylan Pharmaceuticals, Breckenridge Pharmaceutical and Alembin Pharmaceuticals have lost their bid to prove that claims in a patent owned by US company Research Corporation Technologies, were invalid on the grounds of obviousness. 4 February 2019
Asia-Pacific
Chinese artificial intelligence start-up Yitu Technology has launched a new research and development centre in Singapore which will focus partly on applying the technology to medical diagnostics. 1 February 2019
Big Pharma
American pharmaceutical company Pfizer warned investors of little revenue growth to come in 2019, owing partly to expiring exclusivity rights on drugs including Viagra and the seizure medicine Lyrica. 31 January 2019
Americas
Global biopharmaceutical company Celgene has signed a collaboration deal worth up to nearly $1 billion to develop a preclinical therapeutic for the treatment of blood cancers, including leukaemia. 31 January 2019
Americas
A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said. 31 January 2019
Americas
A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers. 30 January 2019
Asia
Thailand’s government has suspended all patents for medical marijuana products, a little more than a month after the country’s parliament voted to approve marijuana for medical use and research. 29 January 2019
Americas
German pharmaceutical company Merck Group has granted US biotech firm Vertex a licence to two DNA-dependent protein kinases inhibitors. 28 January 2019
Asia
Indian pharmaceutical companies should be encouraged to grant compulsory licences and prices of some patented medicines should be capped, an Indian government panel has said. 28 January 2019